Header cover image

Transportation Healthcare Sector

Results

2303

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2303 companies

Orthofix Medical

Market Cap: US$450.2m

Operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally.

OFIX

US$11.30

7D

-1.8%

1Y

-21.8%

Sonida Senior Living

Market Cap: US$447.1m

Owns and operates senior housing communities in the United States.

SNDA

US$24.64

7D

-0.5%

1Y

-6.3%

Altimmune

Market Cap: US$446.9m

A clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases.

ALT

US$5.49

7D

-1.8%

1Y

-19.9%

kneat.com

Market Cap: CA$617.8m

Designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific.

KSI

CA$6.51

7D

-0.6%

1Y

49.3%

Oxford Biomedica

Market Cap: UK£330.7m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

OXB

UK£3.12

7D

2.5%

1Y

-1.0%

Clarity Pharmaceuticals

Market Cap: AU$690.9m

A clinical stage radiopharmaceutical company, engages in research and development and clinical stage radiopharmaceuticals products in Australia and the United States.

CU6

AU$2.15

7D

-7.3%

1Y

-53.3%

Cross Country Healthcare

Market Cap: US$443.6m

Provides talent management services for healthcare clients in the United States.

CCRN

US$13.43

7D

-2.5%

1Y

-7.8%

Tilray Brands

Market Cap: US$443.1m

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.

TLRY

US$0.45

7D

3.9%

1Y

-75.2%

Atai Life Sciences

Market Cap: US$442.7m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada.

ATAI

US$2.31

7D

20.9%

1Y

41.7%

Zenas BioPharma

Market Cap: US$441.8m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies.

ZBIO

US$9.23

7D

-15.6%

1Y

n/a

PureTech Health

Market Cap: UK£325.2m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

PRTC

UK£1.35

7D

0.3%

1Y

-40.7%

Senseonics Holdings

Market Cap: US$436.8m

A commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally.

SENS

US$0.53

7D

6.1%

1Y

20.6%

SIGA Technologies

Market Cap: US$434.4m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

SIGA

US$6.09

7D

-0.7%

1Y

-17.7%

Bioventus

Market Cap: US$433.3m

A medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally.

BVS

US$6.53

7D

0.5%

1Y

-4.1%

Septerna

Market Cap: US$430.0m

A clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.

SEPN

US$9.72

7D

7.3%

1Y

n/a

Oruka Therapeutics

Market Cap: US$428.3m

A clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications.

ORKA

US$11.47

7D

8.4%

1Y

n/a

Paragon Care

Market Cap: AU$662.1m

Distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia.

PGC

AU$0.40

7D

-2.4%

1Y

n/a

Healius

Market Cap: AU$657.2m

Provides specialty diagnostic services to consumer and practitioners in Australia.

HLS

AU$0.91

7D

-13.0%

1Y

-27.9%

MBX Biosciences

Market Cap: US$421.1m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders.

MBX

US$12.52

7D

2.2%

1Y

n/a

Amylyx Pharmaceuticals

Market Cap: US$420.7m

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

AMLX

US$4.79

7D

-11.8%

1Y

186.8%

Development Technologies

Market Cap: US$420.0m

Pegasus Pharmaceuticals Inc. manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies.

DVTC

US$20.00

7D

0%

1Y

455.6%

Vitalhub

Market Cap: CA$579.0m

Provides technology and software solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally.

VHI

CA$10.20

7D

-0.9%

1Y

47.2%

Autolus Therapeutics

Market Cap: US$417.8m

A clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in United Kingdom and internationally.

AUTL

US$1.65

7D

12.2%

1Y

-59.0%

Knight Therapeutics

Market Cap: CA$577.8m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

GUD

CA$5.76

7D

0%

1Y

-4.2%

Precigen

Market Cap: US$416.2m

A discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases.

PGEN

US$1.37

7D

3.8%

1Y

5.4%

NeuroPace

Market Cap: US$415.2m

Operates as a medical device company in the United States.

NPCE

US$12.46

7D

-31.3%

1Y

84.9%

Personalis

Market Cap: US$414.2m

Develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.

PSNL

US$4.70

7D

-0.4%

1Y

260.2%

Surmodics

Market Cap: US$412.0m

Provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally.

SRDX

US$29.20

7D

0.3%

1Y

-30.6%

Faron Pharmaceuticals Oy

Market Cap: UK£305.3m

Operates as a clinical stage drug discovery and development company.

FARN

UK£2.45

7D

9.9%

1Y

38.0%

ORIC Pharmaceuticals

Market Cap: US$410.9m

A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States.

ORIC

US$5.97

7D

1.7%

1Y

-29.3%

MeiraGTx Holdings

Market Cap: US$409.1m

A clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases.

MGTX

US$5.10

7D

-3.8%

1Y

2.0%

Savara

Market Cap: US$408.7m

A clinical stage biopharmaceutical company, focuses on rare respiratory diseases.

SVRA

US$2.14

7D

-26.6%

1Y

-48.6%

Sage Therapeutics

Market Cap: US$408.3m

A biopharmaceutical company, develops and commercializes brain health medicines.

SAGE

US$6.48

7D

-4.7%

1Y

-40.3%

CytoDyn

Market Cap: US$406.2m

A clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications.

CYDY

US$0.34

7D

-6.1%

1Y

38.7%

Zhengye Biotechnology Holding

Market Cap: US$405.7m

Engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China.

ZYBT

US$8.80

7D

-1.0%

1Y

n/a

Tectonic Therapeutic

Market Cap: US$402.3m

A biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs).

TECX

US$21.55

7D

-4.6%

1Y

n/a

Page 13 of 64